Clinical Trials
49
Active:1
Completed:33
Trial Phases
4 Phases
Phase 1:9
Phase 3:6
Phase 4:9
+1 more phases
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (48 trials with phase data)• Click on a phase to view related trials
Not Applicable
24 (50.0%)Phase 1
9 (18.8%)Phase 4
9 (18.8%)Phase 3
6 (12.5%)Short-term Use of Dapagliflozin to Protect Kidney Function in CKD Patients
Phase 4
- Conditions
- Renal Insufficiency, ChronicCardiac CatheterizationPercutaneous Coronary Intervention
- Interventions
- First Posted Date
- 2022-02-04
- Last Posted Date
- 2022-02-04
- Lead Sponsor
- Dong-A University
- Target Recruit Count
- 600
- Registration Number
- NCT05225077
- Locations
- 🇰🇷
Dong A University Hospital, Busan, Korea, Republic of
Optimal Dosage of Ticagrelor in Korean Patients With AMI
Phase 4
- Conditions
- Acute Myocardial InfarctionTicagrelor
- Interventions
- First Posted Date
- 2022-01-27
- Last Posted Date
- 2022-01-27
- Lead Sponsor
- Dong-A University
- Target Recruit Count
- 120
- Registration Number
- NCT05210595
- Locations
- 🇰🇷
DongA University Hospital, Busan, Korea, Republic of
Ticagrelor De-escalation Strategy in East Asian Patients With AMI
Phase 4
- Conditions
- Acute Myocardial Infarction
- Interventions
- First Posted Date
- 2021-02-16
- Last Posted Date
- 2021-02-16
- Lead Sponsor
- Dong-A University
- Target Recruit Count
- 2000
- Registration Number
- NCT04755387
- Locations
- 🇰🇷
DongA University Hospital, Busan, Korea, Republic of
3 Months Versus 12 Months Dual Antiplatelet Therapy After Drug-eluting Stent Implantation in STEMI
Phase 4
- Conditions
- ST Elevation Myocardial Infarction
- Interventions
- First Posted Date
- 2020-09-30
- Last Posted Date
- 2020-12-22
- Lead Sponsor
- Dong-A University
- Target Recruit Count
- 1002
- Registration Number
- NCT04570345
- Locations
- 🇰🇷
Department of Internal Medicine,Dong-A University College of Medicine, Busan, Korea, Republic of
Combination of Olmesartan Effect on Myocardial Viability of Patients With Dilated Cardiomyopathy
Not Applicable
- Conditions
- Dilated Cardiomyopathy
- First Posted Date
- 2019-11-22
- Last Posted Date
- 2020-08-26
- Lead Sponsor
- Dong-A University
- Target Recruit Count
- 40
- Registration Number
- NCT04174456
- Locations
- 🇰🇷
Department of Internal Medicine,Dong-A University College of Medicine, Busan, Korea, Republic of
- Prev
- 1
- 2
- 3
- 4
- 5
- 6
- 7
- Next
News
No news found